Ozempic's reformulated-for-weight-loss cousin, Wegovy (also semaglutide), saw sales soar soon after its launch as well
The results demonstrated that the 25mg daily pill delivered clinically meaningful weight loss: Average weight loss of 13.6-16.6% compared to 2.2-2.7% with placebo 76% of participants achieved at least 5% weight loss versus 31% on placebo Over 30% achieved 20% or greater weight loss Significant improvements in blood pressure, cholesterol, and inflammatory markers These results are comparable to what weve seen with injectable Wegovy, which typically produces 12-15% weight loss
with type 2 diabetes and found that those who took semaglutide had lower rates of cognitive decline than those who took other medications to treat type 2 diabetes
Dietary patterns that support optimal hormone production and seminal plasma quality prefer whole foods, lean protein, beneficial fats, and plenty of vegetables and fruits
Perraudeau et al 2020 doi: 10.1136/bmjdrc-2020-001319 About Pendulum Therapeutics Pendulum Therapeutics is a biotechnology company pioneering next-generation microbiome innovations designed to improve human health